Related by context. Frequent words. (Click for all words.) 62 poor metabolizers 62 neuropsychiatric symptoms 61 renal toxicity 61 MERLIN TIMI 61 multivariate analyzes 60 surrogate markers 60 extrapyramidal symptoms 60 hyperbilirubinemia 59 metabolic parameters 59 prolactin levels 59 Combination therapy 59 serum calcium 58 nephrotoxicity 58 QTc prolongation 58 placebo controlled studies 58 Observational studies 58 platelet reactivity 58 COPD exacerbations 58 coadministration 58 androgen deprivation 58 ziprasidone 58 SERMs 58 fluvastatin 57 fluoxetine Prozac 57 noninferiority 57 CMV infection 57 normotensive 57 lipid abnormalities 57 paclitaxel eluting stents 57 teratogenic 57 Antihypertensive 57 fulvestrant 57 lipid levels 57 TYGACIL 57 PREZISTA r 57 HIV uninfected 57 seroprotection 57 juvenile idiopathic arthritis 57 APTIVUS 57 elevated CRP 57 psychosocial functioning 57 6R BH4 57 Randomized controlled 56 calcineurin inhibitors 56 therapeutic regimens 56 antihypertensive therapy 56 nonadherence 56 cardiovascular morbidity 56 subgroup analyzes 56 generalizability 56 T2DM 56 aripiprazole 56 CYP#D# 56 causal relation 56 placebo controlled trials 56 Focalin XR 56 HSCT 56 antibiotic prophylaxis 56 pharmacokinetics PK 56 guanfacine 56 thrombophilia 56 tocilizumab 56 tigecycline 56 placebo controlled clinical 56 lanthanum carbonate 56 paliperidone 56 hyperglycaemia 56 neuroleptics 56 glitazones 56 placebo controlled clinical trials 56 advanced adenomas 56 #mg/day [001] 56 cardiac toxicity 56 virologic response 56 virologic 56 glucose homeostasis 56 hepatotoxicity 55 montelukast 55 nelfinavir 55 analgesic efficacy 55 Lovastatin 55 asthma exacerbations 55 statin medications 55 morbidity mortality 55 serum vitamin D 55 potentially modifiable 55 superficial bladder cancer 55 pharmacodynamic effects 55 voriconazole 55 p = .# [002] 55 serum concentrations 55 attention-deficit/hyperactivity disorder ADHD 55 virologic failure 55 Eltrombopag 55 Quetiapine 55 severe renal impairment 55 nonobese 55 ALLHAT 55 lipid profiles 55 beta blocker therapy 55 efficacy endpoint